Detailed price information for Psyence Biomedical Ltd (PBM-Q) from The Globe and Mail including charting and trades.

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

PI (Physik Instrumente), a global leader in precision motion control and nanopositioning systems, is pleased to announce progress in the construction of its new production facility in Shrewsbury, ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch ...

India is the world’s largest supplier of generic drugs, with a 20 percent share in the global supply in terms of volume ... are part of the Pharmacy Benefit Management (PBM) industry, which ensures ...

Attorney General Gordon C. Rhea of the U.S. Virgin Islands has joined a bipartisan coalition of 38 attorneys generalfrom ...

UnitedHealth is the parent company of Optum Rx, one of the biggest PBMs. A PBM helps employer-sponsored health plans and ...